価格表

在庫・価格 : 2024年06月08日 18時57分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-IKK beta, Mouse-Mono(10AG2) - BSA Free
データシート※最新のデータシートでない場合があります
NB100-56509SS NOVノバス バイオロジカルス
Novus biologicals, LLC
0.025 mg ¥31,000
(未発注)
追加

在庫・価格 : 2024年06月08日 18時57分 現在

Anti-IKK beta, Mouse-Mono(10AG2) - BSA Free

  • 商品コード:NB100-56509SS
  • メーカー:NOV
  • 包装:0.025mg
  • 価格: ¥31,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Sandur SK et al. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) suppresses NF-kappaB activation and NF-kappaB-regulated gene products through modulation of p65 and IkappaBalpha kinase activation, leading to potentiation of apoptosis induced by cytokine
Sandur SK et al
2006/01/01
Applications: WB PubMed
2 Phromnoi K et al. A novel pentamethoxyflavone down-regulates tumor cell survival and proliferative and angiogenic gene products through inhibition of IκB kinase activation and sensitizes tumor cells to apoptosis by cytokines and chemotherapeutic age
Phromnoi K et al
2011/01/01
Species: Human, Applications: WB PubMed
3 Takada Y et al. Protein farnesyltransferase inhibitor (SCH 66336) abolishes NF-kappaB activation induced by various carcinogens and inflammatory stimuli leading to suppression of NF-kappaB-regulated gene expression and up-regulation of apoptosis. J. Biol.
Takada Y et al
2004/01/01
Applications: WB PubMed
4 Takada Y et al. Flavopiridol inhibits NF-kappaB activation induced by various carcinogens and inflammatory agents through inhibition of IkappaBalpha kinase and p65 phosphorylation: abrogation of cyclin D1, cyclooxygenase-2, and matrix metalloprotease-9. J
Takada Y et al
2004/01/01
Applications: WB PubMed
5 Shishodia S et al. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products. Cancer Res. 2005 Oct;65(20):
Shishodia S et al
2005/01/01
Applications: WB PubMed
6 Shishodia S et al. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synt
Shishodia S et al
2004/01/01
Applications: WB PubMed
7 Ichikawa H et al. Identification of a novel blocker of I kappa B alpha kinase that enhances cellular apoptosis and inhibits cellular invasion through suppression of NF-kappa B-regulated gene products. J. Immunol. 2005 Jun;174(11):7383-92
Ichikawa H et al
2005/01/01
Applications: WB PubMed
8 Takada Y et al. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor. J. Biol. Chem. 2004 Sep;279(38):39541-54
Takada Y et al
2004/01/01
Applications: WB PubMed
9 Shishodia S et al. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem. Pharmacol. 2005 Sep;70(5):700-13
Shishodia S et al
2005/01/01
Applications: PubMed
10 Kasinski AL et al. Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24), a novel monoketone analog of curcumin. Mol. Pharmacol. 2008 Sep;74(3):654-61
Kasinski AL et al
2008/01/01
Species: Human, Applications: WB PubMed
11 Miller BS et al. Complete reconstitution of human IkappaB kinase (IKK) complex in yeast. Assessment of its stoichiometry and the role of IKKgamma on the complex activity in the absence of stimulation. J. Biol. Chem. 2001 Sep;276(39):36320-6
Miller BS et al
2001/01/01
Applications: WB PubMed
12 Ichikawa H et al. Guggulsterone inhibits osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand and by tumor cells by suppressing nuclear factor-kappaB activation. Clin. Cancer Res. 2006 Jan;12(2):662-8
Ichikawa H et al
2006/01/01
Applications: WB PubMed
13 Takada Y et al. Suberoylanilide hydroxamic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing nuclear factor-kappaB activation. J. Biol. Chem. 2006 Mar;281(9):5612-22
Takada Y et al
2006/01/01
Applications: WB PubMed
14 Huang J et al. HTLV-1 Tax is a critical lipid raft modulator that hijacks IkappaB kinases to the microdomains for persistent activation of NF-kappaB. J. Biol. Chem. 2009 Mar;284(10):6208-17
Huang J et al
2009/01/01
Species: Human, Applications: WB PubMed
15 Shishodia S et al. Guggulsterone inhibits NF-kappaB and IkappaBalpha kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis. J. Biol. Chem. 2004 Nov;279(45):47148-58
Shishodia S et al
2004/01/01
Species: Human, Applications: WB PubMed
16 Luedde T et al. Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury. J. Clin. Invest. 2005 Apr;115(4):849-59
Luedde T et al
2005/01/01
Applications: PubMed
17 Anto RJ et al. Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2. Carcinogenesis 2002 Sep;23(9):1511-8
Anto RJ et al
2002/01/01
Applications: WB PubMed
18 Sethi G et al. Indirubin enhances tumor necrosis factor-induced apoptosis through modulation of nuclear factor-kappa B signaling pathway. J. Biol. Chem. 2006 Aug;281(33):23425-35
Sethi G et al
2006/01/01
Applications: WB PubMed
19 Manna SK et al. Leflunomide suppresses TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal protein kinase, and apoptosis. J. Immunol. 2000 Nov;165(10):5962-9
Manna SK et al
2000/01/01
Applications: WB PubMed
20 Vunta H et al. The anti-inflammatory effects of selenium are mediated through 15-deoxy-Delta12,14-prostaglandin J2 in macrophages. J. Biol. Chem. 2007 Jun;282(25):17964-73
Vunta H et al
2007/01/01
Applications: PubMed
21 Kunnumakkara AB et al. Coronarin D, a labdane diterpene, inhibits both constitutive and inducible nuclear factor-kappa B pathway activation, leading to potentiation of apoptosis, inhibition of invasion, and suppression of osteoclastogenesis. Mol. Cancer T
Kunnumakkara AB et al
2008/01/01
Species: Human, Applications: WB PubMed
22 Takada Y et al. Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis. J. Biol. Chem. 20
Takada Y et al
2004/01/01
Species: Human, Applications: WB PubMed
23 Nenci A et al. Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling. Hum. Mol. Genet. 2006 Feb;15(4):531-42
Nenci A et al
2006/01/01
Applications: PubMed
24 Jackson-Bernitsas DG et al. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Oncogene 2007 Mar;26(10):1385-97
Jackson-Bernitsas DG et al
2007/01/01
Applications: WB PubMed
25 Majumdar S et al. Adenosine suppresses activation of nuclear factor-kappaB selectively induced by tumor necrosis factor in different cell types. Oncogene 2003 Feb;22(8):1206-18
Majumdar S et al
2003/01/01
Applications: WB PubMed
26 Santos M et al. Impaired NF-kappa B activation and increased production of tumor necrosis factor alpha in transgenic mice expressing keratin K10 in the basal layer of the epidermis. J. Biol. Chem. 2003 Apr;278(15):13422-30
Santos M et al
2003/01/01
Species: Mouse, Applications: WB PubMed
27 Ashikawa K et al. Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation. J. Immunol. 2002 Dec;169(11):6490-7
Ashikawa K et al
2002/01/01
Applications: WB, IP PubMed
28 Pandey MK et al. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis. Cancer Res. 2008 Jul;68(13):5370-9
Pandey MK et al
2008/01/01
Species: Human, Applications: WB PubMed
29 Lamothe B et al. TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation. Biochem. Biophys. Res. Commun. 2007 Aug;359(4):1044-9
Lamothe B et al
2007/01/01
Applications: WB PubMed
30 Page A et al. IKKβ overexpression leads to pathologic lesions in stratified epithelia and exocrine glands and to tumoral transformation of oral epithelia. Mol. Cancer Res. 2011 Oct;9(10):1329-38
Page A et al
2011/01/01
Species: Mouse, Applications: WB PubMed
31 Buhrmann C et al. Sirtuin-1 (SIRT1) is required for promoting chondrogenic differentiation of mesenchymal stem cells. J. Biol. Chem. 2014 Aug;289(32):22048-62
Buhrmann C et al
2014/01/01
Species: Human, Applications: IP, WB PubMed
32 Majumdar S et al. Methotrexate suppresses NF-kappaB activation through inhibition of IkappaBalpha phosphorylation and degradation. J. Immunol. 2001 Sep;167(5):2911-20
Majumdar S et al
2001/01/01
Applications: WB PubMed
33 Beraza N et al. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury. Gastroenterology 2007 Jun;132(7):2504-17
Beraza N et al
2007/01/01
Species: Mouse, Applications: IP PubMed
34 Leis H et al. Glucocorticoid Receptor Counteracts Tumorigenic Activity of Akt in Skin through Interference with the Phosphatidylinositol 3-Kinase Signaling Pathway. Mol. Endocrinol. 2004 Feb;18(2):303-11
Leis H et al
2004/01/01
Species: Mouse, Applications: WB PubMed
35 Majumdar S et al. Thalidomide suppresses NF-kappa B activation induced by TNF and H2O2, but not that activated by ceramide, lipopolysaccharides, or phorbol ester. J. Immunol. 2002 Mar;168(6):2644-51
Majumdar S et al
2002/01/01
Applications: IP PubMed
36 Bimonte S et al. Curcumin inhibits tumor growth and angiogenesis in an orthotopic mouse model of human pancreatic cancer. Biomed Res Int 2013;2013:810423
Bimonte S et al
2013/01/01
Species: Human, Applications: WB PubMed
37 Breuer R et al. The protein phosphatase 2A regulatory subunit B56γ mediates suppression of T cell receptor (TCR)-induced nuclear factor-κB (NF-κB) activity. J. Biol. Chem. 2014 May;289(21):14996-5004
Breuer R et al
2014/01/01
Species: Human, Applications: WB PubMed
38 Gray CM et al. Noncanonical NF-κB signaling is limited by classical NF-κB activity. Sci Signal 2014 Feb;7(311):ra13
Gray CM et al
2014/01/01
Species: Mouse, Applications: WB PubMed
39 Jin HS et al. cIAP1, cIAP2, and XIAP act cooperatively via nonredundant pathways to regulate genotoxic stress-induced nuclear factor-kappaB activation. Cancer Res. 2009 Mar;69(5):1782-91
Jin HS et al
2009/01/01
Applications: IP PubMed
40 Paul S et al. T cell receptor signals to NF-κB are transmitted by a cytosolic p62-Bcl10-Malt1-IKK signalosome. Sci Signal 2014 May;7(325):ra45
Paul S et al
2014/01/01
Species: Mouse, Applications: ICC/IF PubMed
41 Herrmann O et al. IKK mediates ischemia-induced neuronal death. Nat. Med. 2005 Dec;11(12):1322-9
Herrmann O et al
2005/01/01
Species: Mouse, Applications: WB PubMed
42 Das U et al. Role of ferulic acid in the amelioration of ionizing radiation induced inflammation: a murine model. PLoS ONE 2014;9(5):e97599
Das U et al
2014/01/01
Species: Mouse, Applications: WB PubMed
43 Delhase M et al. TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2. Proc. Natl. Acad. Sci. U.S.A. 2012 Jan;109(4):E177-86
Delhase M et al
2012/01/01
Applications: PubMed
44 Ren T et al. HTLV-1 Tax deregulates autophagy by recruiting autophagic molecules into lipid raft microdomains. Oncogene 2013 Dec;
Ren T et al
2013/01/01
Species: Human, Applications: WB PubMed
  • No.: 1
  • 文献情報:
    Sandur SK et al. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) suppresses NF-kappaB activation and NF-kappaB-regulated gene products through modulation of p65 and IkappaBalpha kinase activation, leading to potentiation of apoptosis induced by cytokine
    Sandur SK et al
    2006/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Phromnoi K et al. A novel pentamethoxyflavone down-regulates tumor cell survival and proliferative and angiogenic gene products through inhibition of IκB kinase activation and sensitizes tumor cells to apoptosis by cytokines and chemotherapeutic age
    Phromnoi K et al
    2011/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Takada Y et al. Protein farnesyltransferase inhibitor (SCH 66336) abolishes NF-kappaB activation induced by various carcinogens and inflammatory stimuli leading to suppression of NF-kappaB-regulated gene expression and up-regulation of apoptosis. J. Biol.
    Takada Y et al
    2004/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Takada Y et al. Flavopiridol inhibits NF-kappaB activation induced by various carcinogens and inflammatory agents through inhibition of IkappaBalpha kinase and p65 phosphorylation: abrogation of cyclin D1, cyclooxygenase-2, and matrix metalloprotease-9. J
    Takada Y et al
    2004/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Shishodia S et al. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products. Cancer Res. 2005 Oct;65(20):
    Shishodia S et al
    2005/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Shishodia S et al. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synt
    Shishodia S et al
    2004/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Ichikawa H et al. Identification of a novel blocker of I kappa B alpha kinase that enhances cellular apoptosis and inhibits cellular invasion through suppression of NF-kappa B-regulated gene products. J. Immunol. 2005 Jun;174(11):7383-92
    Ichikawa H et al
    2005/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Takada Y et al. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor. J. Biol. Chem. 2004 Sep;279(38):39541-54
    Takada Y et al
    2004/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Shishodia S et al. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem. Pharmacol. 2005 Sep;70(5):700-13
    Shishodia S et al
    2005/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Kasinski AL et al. Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24), a novel monoketone analog of curcumin. Mol. Pharmacol. 2008 Sep;74(3):654-61
    Kasinski AL et al
    2008/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Miller BS et al. Complete reconstitution of human IkappaB kinase (IKK) complex in yeast. Assessment of its stoichiometry and the role of IKKgamma on the complex activity in the absence of stimulation. J. Biol. Chem. 2001 Sep;276(39):36320-6
    Miller BS et al
    2001/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Ichikawa H et al. Guggulsterone inhibits osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand and by tumor cells by suppressing nuclear factor-kappaB activation. Clin. Cancer Res. 2006 Jan;12(2):662-8
    Ichikawa H et al
    2006/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Takada Y et al. Suberoylanilide hydroxamic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing nuclear factor-kappaB activation. J. Biol. Chem. 2006 Mar;281(9):5612-22
    Takada Y et al
    2006/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Huang J et al. HTLV-1 Tax is a critical lipid raft modulator that hijacks IkappaB kinases to the microdomains for persistent activation of NF-kappaB. J. Biol. Chem. 2009 Mar;284(10):6208-17
    Huang J et al
    2009/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Shishodia S et al. Guggulsterone inhibits NF-kappaB and IkappaBalpha kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis. J. Biol. Chem. 2004 Nov;279(45):47148-58
    Shishodia S et al
    2004/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Luedde T et al. Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury. J. Clin. Invest. 2005 Apr;115(4):849-59
    Luedde T et al
    2005/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Anto RJ et al. Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2. Carcinogenesis 2002 Sep;23(9):1511-8
    Anto RJ et al
    2002/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Sethi G et al. Indirubin enhances tumor necrosis factor-induced apoptosis through modulation of nuclear factor-kappa B signaling pathway. J. Biol. Chem. 2006 Aug;281(33):23425-35
    Sethi G et al
    2006/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Manna SK et al. Leflunomide suppresses TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal protein kinase, and apoptosis. J. Immunol. 2000 Nov;165(10):5962-9
    Manna SK et al
    2000/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Vunta H et al. The anti-inflammatory effects of selenium are mediated through 15-deoxy-Delta12,14-prostaglandin J2 in macrophages. J. Biol. Chem. 2007 Jun;282(25):17964-73
    Vunta H et al
    2007/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Kunnumakkara AB et al. Coronarin D, a labdane diterpene, inhibits both constitutive and inducible nuclear factor-kappa B pathway activation, leading to potentiation of apoptosis, inhibition of invasion, and suppression of osteoclastogenesis. Mol. Cancer T
    Kunnumakkara AB et al
    2008/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Takada Y et al. Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis. J. Biol. Chem. 20
    Takada Y et al
    2004/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Nenci A et al. Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling. Hum. Mol. Genet. 2006 Feb;15(4):531-42
    Nenci A et al
    2006/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Jackson-Bernitsas DG et al. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Oncogene 2007 Mar;26(10):1385-97
    Jackson-Bernitsas DG et al
    2007/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Majumdar S et al. Adenosine suppresses activation of nuclear factor-kappaB selectively induced by tumor necrosis factor in different cell types. Oncogene 2003 Feb;22(8):1206-18
    Majumdar S et al
    2003/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Santos M et al. Impaired NF-kappa B activation and increased production of tumor necrosis factor alpha in transgenic mice expressing keratin K10 in the basal layer of the epidermis. J. Biol. Chem. 2003 Apr;278(15):13422-30
    Santos M et al
    2003/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Ashikawa K et al. Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation. J. Immunol. 2002 Dec;169(11):6490-7
    Ashikawa K et al
    2002/01/01
  • 備考:
    Applications: WB, IP
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Pandey MK et al. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis. Cancer Res. 2008 Jul;68(13):5370-9
    Pandey MK et al
    2008/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Lamothe B et al. TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation. Biochem. Biophys. Res. Commun. 2007 Aug;359(4):1044-9
    Lamothe B et al
    2007/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Page A et al. IKKβ overexpression leads to pathologic lesions in stratified epithelia and exocrine glands and to tumoral transformation of oral epithelia. Mol. Cancer Res. 2011 Oct;9(10):1329-38
    Page A et al
    2011/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Buhrmann C et al. Sirtuin-1 (SIRT1) is required for promoting chondrogenic differentiation of mesenchymal stem cells. J. Biol. Chem. 2014 Aug;289(32):22048-62
    Buhrmann C et al
    2014/01/01
  • 備考:
    Species: Human, Applications: IP, WB
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Majumdar S et al. Methotrexate suppresses NF-kappaB activation through inhibition of IkappaBalpha phosphorylation and degradation. J. Immunol. 2001 Sep;167(5):2911-20
    Majumdar S et al
    2001/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Beraza N et al. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury. Gastroenterology 2007 Jun;132(7):2504-17
    Beraza N et al
    2007/01/01
  • 備考:
    Species: Mouse, Applications: IP
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Leis H et al. Glucocorticoid Receptor Counteracts Tumorigenic Activity of Akt in Skin through Interference with the Phosphatidylinositol 3-Kinase Signaling Pathway. Mol. Endocrinol. 2004 Feb;18(2):303-11
    Leis H et al
    2004/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Majumdar S et al. Thalidomide suppresses NF-kappa B activation induced by TNF and H2O2, but not that activated by ceramide, lipopolysaccharides, or phorbol ester. J. Immunol. 2002 Mar;168(6):2644-51
    Majumdar S et al
    2002/01/01
  • 備考:
    Applications: IP
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Bimonte S et al. Curcumin inhibits tumor growth and angiogenesis in an orthotopic mouse model of human pancreatic cancer. Biomed Res Int 2013;2013:810423
    Bimonte S et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Breuer R et al. The protein phosphatase 2A regulatory subunit B56γ mediates suppression of T cell receptor (TCR)-induced nuclear factor-κB (NF-κB) activity. J. Biol. Chem. 2014 May;289(21):14996-5004
    Breuer R et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Gray CM et al. Noncanonical NF-κB signaling is limited by classical NF-κB activity. Sci Signal 2014 Feb;7(311):ra13
    Gray CM et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Jin HS et al. cIAP1, cIAP2, and XIAP act cooperatively via nonredundant pathways to regulate genotoxic stress-induced nuclear factor-kappaB activation. Cancer Res. 2009 Mar;69(5):1782-91
    Jin HS et al
    2009/01/01
  • 備考:
    Applications: IP
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Paul S et al. T cell receptor signals to NF-κB are transmitted by a cytosolic p62-Bcl10-Malt1-IKK signalosome. Sci Signal 2014 May;7(325):ra45
    Paul S et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Herrmann O et al. IKK mediates ischemia-induced neuronal death. Nat. Med. 2005 Dec;11(12):1322-9
    Herrmann O et al
    2005/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Das U et al. Role of ferulic acid in the amelioration of ionizing radiation induced inflammation: a murine model. PLoS ONE 2014;9(5):e97599
    Das U et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Delhase M et al. TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2. Proc. Natl. Acad. Sci. U.S.A. 2012 Jan;109(4):E177-86
    Delhase M et al
    2012/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Ren T et al. HTLV-1 Tax deregulates autophagy by recruiting autophagic molecules into lipid raft microdomains. Oncogene 2013 Dec;
    Ren T et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed